Cifuentes M E, Rey F E, Carretero O A, Pagano P J
Hypertension and Vascular Research Division, Henry Ford Hospital, Detroit, Michigan 48202-2689, USA.
Am J Physiol Heart Circ Physiol. 2000 Nov;279(5):H2234-40. doi: 10.1152/ajpheart.2000.279.5.H2234.
Although NAD(P)H oxidase-derived superoxide (O(2)(-)) is increased during the development of angiotensin II (ANG II)-dependent hypertension, vascular regulation at the protein level has not been reported. We have shown that four major components of NAD(P)H oxidase are located primarily in the vascular adventitia as a primary source of vascular O(2)(-). Here we compare vascular levels of O(2)(-) and NAD(P)H oxidase in normotensive and ANG II-infused hypertensive mice and show that, after 7 days of ANG II infusion (750 microg. kg(-1). day(-1) ip) in C57B1/6 mice, systolic blood pressure was increased compared with that after sham infusion, concomitant with increased O(2)(-) in the thoracic aorta as measured using lucigenin (25 microM)-enhanced chemiluminescence. Both p67(phox) and gp91(phox) were detectable by Western blotting in aortic homogenates, and we observed increased protein levels of NAD(P)H oxidase subunits. These ANG II-induced increases were normalized by simultaneous treatment with the AT(1) receptor antagonist losartan. Moreover, the primary location of these subunits was the adventitia as detected immunohistochemically. Our results suggest that ANG II-induced increases in O(2)(-) are due to increased adventitial NAD(P)H oxidase activity, brought about by the heightened expression and interaction of its components.
尽管在血管紧张素II(ANG II)依赖性高血压发展过程中,NAD(P)H氧化酶衍生的超氧化物(O(2)(-))会增加,但尚未见关于蛋白质水平血管调节的报道。我们已经表明,NAD(P)H氧化酶的四个主要成分主要位于血管外膜,是血管O(2)(-)的主要来源。在此,我们比较了正常血压小鼠和输注ANG II的高血压小鼠的血管O(2)(-)水平和NAD(P)H氧化酶水平,结果显示,在C57Bl/6小鼠中输注ANG II(750μg·kg(-1)·天(-1),腹腔注射)7天后,收缩压比假输注后升高,同时使用光泽精(25μM)增强化学发光法测得胸主动脉中的O(2)(-)增加。通过蛋白质印迹法可在主动脉匀浆中检测到p67(phox)和gp91(phox),并且我们观察到NAD(P)H氧化酶亚基的蛋白质水平增加。这些ANG II诱导的增加通过同时用AT(1)受体拮抗剂氯沙坦治疗而恢复正常。此外,通过免疫组织化学检测发现这些亚基的主要位置在外膜。我们的结果表明,ANG II诱导的O(2)(-)增加是由于外膜NAD(P)H氧化酶活性增加所致,这是由其成分的表达增强和相互作用引起的。